NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

用於生物技術,藥物發現和藥物遞送系統的納米顆粒

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

出版商 BCC Research 商品編碼 977430
出版日期 內容資訊 英文 137 Pages
訂單完成後即時交付
價格
用於生物技術,藥物發現和藥物遞送系統的納米顆粒 Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems
出版日期: 2020年12月16日內容資訊: 英文 137 Pages
簡介

全球生物技術,藥物發現和藥物遞送納米顆粒市場將從2020年的834億美元增長到2025年的1,236億美元,從2020年到2025年的複合年增長率為8.2%。據預測。藥物輸送系統市場預計將從2020年的461億美元增長到2025年的620億美元,到2025年的複合年增長率為6.1%。診斷成像和診斷測試市場預計將從2020年的18億美元增長到2025年的31億美元,到2025年的複合年增長率為11.5%。

本報告對生物技術,藥物發現和藥物輸送系統的全球納米顆粒市場進行了調查和分析,並提供了有關市場概況,市場趨勢分析,主要產品,競爭狀況,主要公司等的系統信息。

目錄

第1章簡介

第2章摘要和重點

第3章市場概述

  • 納米粒子的介紹
  • 脂質體
  • 量子點
  • 樹枝狀聚合物
  • 聚合物納米顆粒
  • 納米顆粒概述
  • 生物技術中的納米顆粒
  • 藥物開發中的納米顆粒
  • 藥物輸送系統中的納米顆粒
  • 診斷成像中的納米顆粒
  • 納米顆粒藥物遞送領域的主要公司
  • 主要的納米顆粒/納米晶體藥物利潤

第4章市場細分:按產品類型

  • 生物技術中的納米顆粒
  • 藥物開發中的納米顆粒
  • 藥物輸送系統中的納米顆粒
  • 診斷成像中的納米顆粒
  • 納米生物技術公司和納米醫學公司的分佈

第5章納米粒子的結構

  • 在應用市場中採用納米顆粒
  • LCD
  • 液體載體
  • 脂質體
  • 樹枝狀聚合物
  • 殼聚醣和藻酸鹽
  • 納米晶體
  • 量子點
  • 納米顆粒在遞送藥物中的應用

第6章納米顆粒的生產

  • 如何形成納米顆粒
  • 自組裝生產
  • 穩定方法
  • 藥物引入方法
  • 聚合物納米顆粒
  • 膠束
  • 脂質體
  • 金和矽納米粒子
  • 樹枝狀聚合物
  • 如何將生物分子裝載到納米顆粒上
  • 納米晶體藥物
  • 大規模生產納米顆粒的問題

第7章生物技術中的納米顆粒

  • 研究與開發
  • 幹細胞研究
  • 細胞修復
  • 普通磁性納米粒子/超普通磁性納米粒子
  • 生物傳感器和量子點
  • 納米粒子研究聯合計劃

第8章藥物開發和配製中的納米顆粒

  • 生物分離
  • 快速藥物分析
  • 去除雜質和毒素
  • 使用納米粒子摻入不溶性藥物
  • 生物醫學中的金和銀納米顆粒
  • 開髮用於DNA特異性藥物的DNA納米顆粒

第9章藥物輸送系統中的納米顆粒

  • 納米顆粒在藥物輸送中的應用
  • 納米藥物遞送系統的設計
  • 納米顆粒的藥物穩定性
  • 納米顆粒製備的尺寸均勻性
  • 納米粒子載藥量
  • 從納米顆粒等釋放藥物

第10章體外成像/體內成像

  • 體外成像
  • 診斷成像中的納米顆粒

第11章生物醫學納米顆粒產品

  • 納米顆粒藥物遞送系統/產品
  • 納米顆粒藥物輸送系統的主要公司
  • 納米藥物遞送企業管道
  • 促進納米顆粒產品和營銷的因素
  • 納米顆粒產品開發和營銷的障礙

第12章市場細分:按地區

  • 市場概述和考慮
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區
  • 南美洲
  • 中東/非洲

第13章納米技術在COVID-19疫苗生產中的作用

  • 簡介
  • 一種依靠不同方法的新型日冕病毒
  • COVID-19的結構和滲透
  • COVID-19疫苗的挑戰
  • 疫苗設計中的組成部分和方法等

第14章專利,許可,併購

第15章公司簡介

  • BRISTOL-MYERS SQUIBB CO.
  • CAMURUS AB
  • CERAMISPHERE PTY LTD.
  • CYTIMMUNE SCIENCES
  • GLAXOSMITHKLINE PLC.
  • HOFFMANN-LA ROCHE INC.
  • MERCK & CO. INC.
  • NANOCARRIER CO. LTD.
  • NOVARTIS AG
目錄
Product Code: BIO113C

Highlights:

The global market for nanoparticles in biotechnology, drug development and drug delivery should grow from $83.4 billion in 2020 to $123.6 billion by 2025, at a compound annual growth rate (CAGR) of 8.2% for the period of 2020-2025.

Drug delivery systems market should grow from $46.1 billion in 2020 to $62.0 billion by 2025 at a CAGR of 6.1% through 2025.

Diagnostic imaging, diagnostic testing market should grow from $1.8 billion in 2020 to $3.1 billion by 2025 at a CAGR of 11.5% through 2025.

Report Scope:

The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and drug delivery, and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections.

The report includes analysis of leading and emerging drug products for each nanoparticle type. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.

Market figures are based on revenues at the manufacturer level and are projected in 2019 dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, for new product introductions, expanded markets for existing products, and other factors affecting the market included in this report are forecasts by product, product category and by company.

The study is arranged to offer an overview of existing nanoparticle technology and of drug markets; it is accompanied by nanoproduct, company, geography, and mechanism of action, with forecasts broken down and covered by geographic region or country.

Patent and clinical trial information is reviewed for various candidate nanodrugs. The status of approvals of drugs in each segment by the FDA and regulatory agencies in other countries is reviewed.

Figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies. All market share data presented is on a global basis unless specifically noted.

Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Includes:

  • 43 tables
  • An overview of the global nanoparticles in biotechnology, drug development and drug delivery market
  • Estimation of the market size and analyses of market trends, with data from 2019, estimates for 2020 and projection of CAGR through 2025
  • Highlights of the drug development, formulation, and the development of new drug delivery systems and detailed product analyses within health and wellness subsegments
  • Information on nanomedicine and biomedical nanoparticle products and coverage of the next generation vaccines
  • Evaluation of current market trends, market size, market forecast, and detailed analysis of drivers, challenges, and opportunities affecting market growth
  • Discussion on the role of nanotechnology in COVID-19 vaccine production, components, and methods in the vaccine design for COVID-19 and challenges for vaccine disruptions
  • Assessment of various approaches for the treatment of COVID-19, and detailed description of structure and penetration of corona virus
  • Details of clinical trials of nanoparticle drugs and drug delivery systems
  • A look at the patents, licensing, mergers and acquisitions and market share analysis of the key companies of the industry
  • Company profiles of major players including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Hofmann-La Roche Inc., Merck & Co., and Novartis AG

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Market Estimate
  • Information Sources
  • Primary Research
  • Secondary Research
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

  • Introduction to Nanoparticles
  • Liposomes
  • Quantum Dots
  • Dendrimers
  • Macromolecule Nanoparticles
  • Brief History of Nanoparticles
  • Nanoparticles in Biotechnology
  • Nanoparticles in Drug Development
  • Nanoparticles in Drug Delivery Systems
  • Nanoparticles in Diagnostic Imaging
  • Major Players in Nanoparticle Drug Delivery Field
  • Major Nanoparticle/Nanocrystal Drug Revenues

Chapter 4 Market Breakdown by Product Type

  • Nanoparticles in Biotechnology
  • Nanoparticles in Drug Development
  • Nanoparticles in Drug Delivery Systems
  • Nanoparticles in Diagnostic Imaging
  • Distribution of Nanobiotechnology and Nanomedicine Companies

Chapter 5 Structure of Nanoparticles

  • Adoption of Nanoparticles in Applied Markets
  • Liquid Crystals
  • Liquid Carriers
  • Liposomes
  • Dendrimers
  • Chitosan and Alginate
  • Nanocrystals
  • Quantum Dots
  • Application of Nanoparticles to Drugs Delivered

Chapter 6 Production of Nanoparticles

  • Methods of Nanoparticle Formation
  • Self-Assembly Production
  • Methods of Stabilization
  • Methods of Drug Introduction
  • Polymeric Nanoparticles
  • Micelles
  • Liposomes
  • Gold and Silicon Nanoparticles
  • Dendrimers
  • Methods for Loading Biological Molecules into Nanoparticles
  • Nanocrystal Drugs
  • Problems with Large-Scale Nanoparticles Production

Chapter 7 Nanoparticles in Biotechnology

  • Research and Development
  • Stem Cell Research
  • Cellular Repair
  • Paramagnetic and Superparamagnetic Nanoparticles
  • Biosensors and Quantum Dots
  • Nanoparticle Research Collaborative Programs

Chapter 8 Nanoparticles in Drug Development and Formulation

  • Bio Separations
  • Rapid Drug Analysis
  • Removal of Impurities and Toxins
  • Using Nanoparticles to Incorporate Insoluble Drugs
  • Gold and Silver Nanoparticles in Biomedicine
  • DNA Nanoparticle Development of DNA-Specific Drugs

Chapter 9 Nanoparticles in Drug Delivery Systems

  • Nanoparticles in Drug Delivery Applications
  • Designing a Nanoparticle Drug Delivery System
  • Nanoparticle Drug Stability
  • Size Homogeneity of Nanoparticle Preparations
  • Drug Loading of Nanoparticles
  • Drug Release from Nanoparticles
  • External Triggers for Releasing Drugs from Nanoparticles
  • Binding/Incorporation of Biomolecules to Nanoparticles
  • Nanoparticle Toxicity
  • Large Scale Manufacturing
  • Methods of Administration of Nanoparticle Drugs
  • Oral Administration
  • Injection Administration
  • Transdermal Patch
  • Implantation Administration
  • Inhalation Administration
  • Nanoparticles Suitable for Drug Delivery Systems
  • Lipid-Based Nanoparticles
  • Micelle Nanoparticles
  • Dendrimer Nanoparticles
  • Polymeric Nanoparticles
  • Metal-Based Nanoparticles
  • Biological Macromolecule Nanoparticles
  • Nanocrystals
  • Nanoparticle Drug Delivery Systems Now Available
  • Antibiotic Nanoparticles
  • Anti-Tumor and Small Molecule Delivery by Nanoparticle
  • Release of Anti-Cancer Drugs from Nanoparticles
  • Biomacromolecules Delivered by Nanoparticles
  • Nanoparticles Coating for Drug Delivery Systems
  • Removal of Nanoparticles from the body

Chapter 10 In Vitro and In Vivo Diagnostic Imaging

  • In Vitro Imaging
  • Nanoparticles in Diagnostic Imaging

Chapter 11 Biomedical Nanoparticle Products

  • Nanoparticle Drug Delivery Systems and Products
  • Major Players in Nanoparticle Drug Delivery Systems
  • Company Pipelines for Nanoparticle Drug Delivery
  • Drivers of Nanoparticle Products and Marketing
  • Limiters of Nanoparticle Product Development and Marketing

Chapter 12 Market Breakdown by Region

  • Market Overview and Discussion
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
  • South America
  • Middle East and Africa

Chapter 13 Role of Nanotechnology in COVID-19 Vaccine Production

  • Introduction
  • Novel Coronavirus Relying on Various Approaches
  • Structure of COVID-19 and Penetration
  • Challenges for COVID-19 Vaccines
  • Components and Methods in the Design of Vaccines
  • Antigen
  • Adjuvant
  • Nanoparticle/Nanocarrier
  • Device
  • Next Generation Vaccines Enabled Through Advances in Nanotechnology
  • Conclusion on Nanotechnology Usage Against COVID-19

Chapter 14 Patents, Licensing, Mergers and Acquisitions

  • Recent Licensed, Mergers and Acquisition
  • Recent Licensing Activity, Mergers and Acquisition
  • Recent Deals
  • Nanoparticle Patents

Chapter 15 Company Profiles

  • BRISTOL-MYERS SQUIBB CO.
  • CAMURUS AB
  • CERAMISPHERE PTY LTD.
  • CYTIMMUNE SCIENCES
  • GLAXOSMITHKLINE PLC.
  • HOFFMANN-LA ROCHE INC.
  • MERCK & CO. INC.
  • NANOCARRIER CO. LTD.
  • NOVARTIS AG

List of Tables

  • Summary Table : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Product Type, Through 2025
  • Table 1 : Description of Nanoparticles Used in Drug Delivery and Diagnostic Imaging
  • Table 2 : Applications of Nanoparticles in Biotechnology
  • Table 3 : Applications of Nanoparticles in Drug Development
  • Table 4 : Applications of Nanoparticles in Drug Delivery Systems
  • Table 5 : Nanoparticles Used in Drug Delivery Systems
  • Table 6 : Nanoparticles Used for In vivo Diagnostic Imaging
  • Table 7 : Major Players in Nanoparticle Drug Field
  • Table 8 : Major Nanoparticle/Nanocrystal Drug by Product and Company
  • Table 9 : Global Market for Nanoparticles in Biotechnology, Through 2025
  • Table 10 : Global Market for Nanoparticles in Drug Development and Formulation, Through 2025
  • Table 11 : Global Market for Nanoparticles in Drug Delivery Systems, Through 2025
  • Table 12 : Global Market for Nanoparticles in Diagnostic Imaging Systems, Through 2025
  • Table 13 : Global Distribution of Nanobiotechnology and Nanomedicine Companies
  • Table 14 : Nanoparticles Structure and Properties
  • Table 15 : Nanoparticles Systems Approved for Drug Delivery
  • Table 16 : Sample of Drugs Delivered Through Liposome Nanotechnology
  • Table 17 : Nanoparticles in Biotechnology Applications
  • Table 18 : Nano Biosensor Technology Under Development
  • Table 19 : ETPN Strategic Research and Innovation Agenda
  • Table 20 : Nanoparticles in Drug Development Applications
  • Table 21 : Monoclonal antibody (mAb) Drugs with Potential for Use in Nanoparticles Delivery Systems
  • Table 22 : Solid Lipid Nanoparticles-Reformatted Drugs
  • Table 23 : Nanoparticles in Drug Delivery Applications
  • Table 24 : Standard Routes of Drug Administration
  • Table 25 : Nanoparticle Transdermal Patch Products
  • Table 26 : Type of Nanoparticles Supplied in Drug Delivery Systems
  • Table 27 : Mechanism for Removal of Nanoparticles from the Body
  • Table 28 : Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
  • Table 29 : List of Marketed Products Used in Different Nanotechnology-based Techniques
  • Table 30 : Major Players in Nanoparticle Drug Development and Formulation Market
  • Table 31 : Company Pipeline for Cardiovascular Nanoparticle Drugs
  • Table 32 : Company Pipeline for CNS Disease Nanoparticle Drugs
  • Table 33 : Company Pipeline for GI Disease Nanoparticle Drugs
  • Table 34 : Company Pipeline for Infectious Disease Nanoparticle Drugs
  • Table 35 : Company Pipeline for Cancer Nanoparticle Drugs
  • Table 36 : Company Pipeline for Ophthalmic Nanoparticle Drugs
  • Table 37 : Company Pipeline for Autoimmune Disease Nanoparticle Drugs
  • Table 38 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Region, Through 2025
  • Table 39 : North American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025
  • Table 40 : European Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025
  • Table 41 : Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025
  • Table 42 : Global Nanotechnology, Patents, by Country, 2017-2020
  • Table 43 : Bristol-Myers Squibb Co.: Financials, 2017-2019

List of Figures

  • Summary Figure : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Product Type, 2019-2025
  • Figure 1 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
  • Figure 2 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Region, 2019-2025
  • Figure 3 : Global Market Share for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Region, 2019
  • Figure 4 : North American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
  • Figure 5 : North American Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019
  • Figure 6 : European Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
  • Figure 7 : European Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019
  • Figure 8 : Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
  • Figure 9 : Asia-Pacific Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019
  • Figure 10 : South American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
  • Figure 11 : Middle Eastern and African Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025